APA (7th ed.) Citation

Wanner, C., Cooper, M. E., Johansen, O. E., Toto, R., Rosenstock, J., McGuire, D. K., . . . investigators, t. C. (2021). Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: The CARMELINA randomized controlled trial. Clinical Kidney Journal, 14, 226. https://doi.org/10.1093/ckj/sfaa225

Chicago Style (17th ed.) Citation

Wanner, Christoph, et al. "Effect of Linagliptin Versus Placebo on Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes: The CARMELINA Randomized Controlled Trial." Clinical Kidney Journal 14 (2021): 226. https://doi.org/10.1093/ckj/sfaa225.

MLA (9th ed.) Citation

Wanner, Christoph, et al. "Effect of Linagliptin Versus Placebo on Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes: The CARMELINA Randomized Controlled Trial." Clinical Kidney Journal, vol. 14, 2021, p. 226, https://doi.org/10.1093/ckj/sfaa225.